Literature DB >> 25911892

Clinical characteristics and prognostic factors of gastroenteropancreatic neuroendocrine tumors: a single center experience in China.

Han-kui Hu, Neng-wen Ke, Ang Li, Xiao-jiong Du, Qiang Guo, Wei-ming Hu.   

Abstract

BACKGROUND/AIMS: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a unique subgroup of tumors in the digestive system but with great clinical heterogeneity. The information on clinical characteristics and prognostic factors of Chinese patients is rather limited.
METHODOLOGY: We retrospectively analyzed the clinical features, prognostic factors of this disease in a consecutive cohort (N=294) between January 2007 and December 2012.
RESULTS: Functioning tumors accounted for 9.2%. Rectum was the most predominant GEP-NETs locations. Abdominal pain occurred in 46.5% patients which was the most common initial symptom. G1, G2 and G3 tumors accounted for 41.5%, 34.7% and 23.8%, respectively. Endoscopy provided the highest detection rate of 95.7%. Consistence between endoscopic ultrasound guided fine needle aspiration biopsy (EUS-FNAB) and surgically obtained histological Ki-67 index was 36.4%. Serum CgA test showed a 80.0% consistence with the tissue biopsy. The median follow up duration was 2.8 years (0.02-5.90 years), the median survival was 4.8 years, overall 5-year survival rate was 69.6%. We found colonic localization, tumor size larger than 20 mm, G3 tumor and metastasis were associated with worse outcome (p<0.05).
CONCLUSION: We found both consistence and differences in GEP-NETs characteristics between our study and previous reports.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25911892

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  5 in total

1.  Outcomes of 101 Consecutive Surgical Resections of Gastroenteropancreatic Neuroendocrine Tumours (GEPNETs) at Tata Memorial Hospital: a Referral Bias for Nonfunctional Duodenopancreatic Tumours and the Need for Greater Awareness of GEPNETs as a Distinct Entity.

Authors:  Vinay Gaikwad; Shraddha Patkar; Savio George Barreto; Bhawna Sirohi; Mahesh Goel; Shailesh V Shrikhande
Journal:  Indian J Surg       Date:  2016-02-13       Impact factor: 0.656

2.  Severe Unresponsive Hypoglycemia Associated with Neuroendocrine Tumor of Unknown Primary Site - 18 Years after Rectal Cancer Surgery. Case Report.

Authors:  Octavia Cristina Rusu; Radu Virgil Costea; Cristian Constantin Popa; Andreea Iliesiu; Adrian Dumitru; Gabriel Becheanu; Stefan Ilie Neagu
Journal:  Maedica (Bucur)       Date:  2015-09

3.  A novel predictive model based on preoperative blood neutrophil-to-lymphocyte ratio for survival prognosis in patients with gastric neuroendocrine neoplasms.

Authors:  Long-Long Cao; Jun Lu; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Qi-Yue Chen; Mi Lin; Ru-Hong Tu; Chang-Ming Huang
Journal:  Oncotarget       Date:  2016-07-05

4.  Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms.

Authors:  Mengjie Jiang; Yinuo Tan; Xiaofen Li; Jianfei Fu; Hanguang Hu; Xianyun Ye; Ying Cao; Jinghong Xu; Ying Yuan
Journal:  Gastroenterol Res Pract       Date:  2017-01-17       Impact factor: 2.260

5.  Nomogram based on tumor-associated neutrophil-to-lymphocyte ratio to predict survival of patients with gastric neuroendocrine neoplasms.

Authors:  Long-Long Cao; Jun Lu; Jian-Xian Lin; Chao-Hui Zheng; Ping Li; Jian-Wei Xie; Jia-Bin Wang; Qi-Yue Chen; Mi Lin; Ru-Hong Tu; Chang-Ming Huang
Journal:  World J Gastroenterol       Date:  2017-12-21       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.